Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP36 activates myasthenia gravis anti-skeletal muscle antibody. 2 / 2

| 2

➶

eidos

"As shown in Figures 3F , G , E-cadherin was obviously decreased and alpha-SMA was significantly enhanced in TECs under high glucose , while knockdown of USP36 could effectively reverse the expression of E-cadherin and alpha-SMA , which suggesting that up-regulation of USP36 may be an upstream mechanism for EMT and diabetic tubulointerstitial fibrosis ."

33968925

➶

eidos

"As shown in Figures 3D , E , E-cadherin was significantly enhanced and alpha-SMA was obviously decreased by knockdown of USP36 in TECs ."

33968925

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...